Aljohani, K.; Naguib, G.H.; Mira, A.I.; Alnowaiser, A.; Hamed, M.T.; Abougazia, A.O.; Alzarani, G.A.; Noorsaeed, R.M.; Kayal, R.A.
Mycophenolate Mofetil in the Management of Oral Mucocutaneous Diseases: Current Evidence and Future Perspectives. Oral 2025, 5, 35.
https://doi.org/10.3390/oral5020035
AMA Style
Aljohani K, Naguib GH, Mira AI, Alnowaiser A, Hamed MT, Abougazia AO, Alzarani GA, Noorsaeed RM, Kayal RA.
Mycophenolate Mofetil in the Management of Oral Mucocutaneous Diseases: Current Evidence and Future Perspectives. Oral. 2025; 5(2):35.
https://doi.org/10.3390/oral5020035
Chicago/Turabian Style
Aljohani, Khalid, Ghada H. Naguib, Abdulghani I. Mira, Abeer Alnowaiser, Mohamed T. Hamed, Ahmed O. Abougazia, Ghaida A. Alzarani, Raghad M. Noorsaeed, and Rayyan A. Kayal.
2025. "Mycophenolate Mofetil in the Management of Oral Mucocutaneous Diseases: Current Evidence and Future Perspectives" Oral 5, no. 2: 35.
https://doi.org/10.3390/oral5020035
APA Style
Aljohani, K., Naguib, G. H., Mira, A. I., Alnowaiser, A., Hamed, M. T., Abougazia, A. O., Alzarani, G. A., Noorsaeed, R. M., & Kayal, R. A.
(2025). Mycophenolate Mofetil in the Management of Oral Mucocutaneous Diseases: Current Evidence and Future Perspectives. Oral, 5(2), 35.
https://doi.org/10.3390/oral5020035
